Conditions: Post-Operative Nausea and Vomiting
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 216
Healthy volunteers: no

Brief summary:
A new intravenous medication is being tested for the prevention of the nausea and vomiting that occurs after surgery. This new medication is being compared to another intravenous medication that is already available to patients for this indication.

Detailed description:

Arms:
arm 1: 40 mg MK0517 IV arm 2: 4 mg ondansetron IV

Interventions: intervention 1: Comparator: MK0517 intervention 2: Comparator: ondansetron
Intervention descriptions: intervention 1: a single administration of 40 mg MK0517 by IV immediately prior to surgery intervention 2: a single administration of 4 mg ondansetron by IV immediately prior to surgery

Protocol document: